Louis Chenevert Advice for Others

Many young people want to advance within their career. Working up the corporate ladder is a dream for many people. Louis Chenevert is someone who has had success at multiple companies. Not only is he a smart business leader, but he also has the people skills needed to make a positive impact on various companies.

Louis Chenevert is the type of person who is always ready for a new challenge. Despite a hectic schedule, Louis Chenevert continually looks for new opportunities to make a significant difference in the lives of others.

College and Early Career

When Louis Chenevert was young, he did not know what he wanted to do with his life. He attended the University of Montreal and majored in business. He chose to emphasize in production management because he enjoyed the process of improving manufacturing processes. He graduated and started working at General Motors. He worked at the company for 14 years, and he had a distinguished career during that time frame.

After leaving General Motors, Louis Chenevert decided to take an opportunity at Pratt and Whitney. He enjoyed his time at the company, and he wanted to make a positive impact for the future.

UTC

Louis Chenevert received a job offer to become a prominent executive at United Technologies Corporation in 2006. He accepted the job offer and went to work. During his time at United Technologies Corporation, he made a ton of significant improvements at the company. He became CEO of the company in 2008. Although he is no longer the CEO, he is still passionate about the future of the company.

Louis Chenevert was recently asked to give some advice to young business students. He told students to continually looks for ways to improve their knowledge of technology. Louis Chenevert is a firm believer that technology will make a major impact in several industries in the future. Multiple industries will be massively disrupted by this new technology. Louis Chenevert is always willing to advise young people who want to succeed.

https://www.bloomberg.com/news/articles/2015-09-08/goldman-sachs-hires-former-united-technologies-ceo-chenevert

Ronald Fowlkes: Military Supply

The military is one of the most important thing in our country. They protect u from al outsiders who would seek to destroy or take over our way of life. Their job has several complex functions that must be performed with the right training and the right equipment. If they don’t have these crucial components the entire countries safety could be compromised or destroyed. Fortunately, there are people and groups who have decided to help the military get what they need to do there many jobs successfully. One if the people is Ronald Fowlkes.

Ronald Fowlkes is a former military member himself. While in the military he did many different jobs at one point he was a member of JIEDDO the joint improvised explosive device defeat organization and was tasked with mounting and disabling infantry operations in the combat zone. Some of these operations included work with deadly explosives. Ronald Fowles also has experience as a former Marine as he served from 1989 to 1993 and as a SWAT team member in St. Louis. With over 13 years in law enforcement experience and the even longer time as a military member he has vast experience and knowledge on what the armed forces exactly need for success. That is why his job as the Manager of Business Development with Eagle Industries under FirstStrike is such a good pairing. He is responsible for demonstrating operational development experience and to decides what products will be manufactured and shipped out to retailers. He first noticed FirstStrike while he was in the military and noticed the high quality and the reliability that was characteristic of the gear.

He believes in teamwork as a key component to his entire operation. Under his supervision members from different divisions of the company work together to get products out. He is very focused on the future and re4cently has developed some new sets of gear that are based on laser cutting and tube technology. This new equipment us 40 % lighter than the previous versions and the industry standard. With people like Ronald Fowlkes on the case the military will have all of what they need to be successful.

 

Jordan Lindsey Forex Gains Ongoing

Jordan Lindsey knows that value is everywhere in the Forex market. At this point the daily average Forex trading volume exceeds 1.8 trillion dollars daily, yet we have seen weakness in the US dollar considerably over the past year. More recently there is strength in the British pound. That strength drives a number of factors, a key factor being rising inflation. With the bullish trend of the GBP/USD now more than a year old Lindsey’s proposition that 7 percent returns are attainable on a continual monthly basis lets traders know they still have an edge.

Growing up, Jordan Lindsey had the mind of an entrepreneur. At a young age he knew that he wanted to be the creator of something that would change the world. Even then he was designing businesses and searching for ways to make things better. It is Jordan Lindsay’s belief that failure leads to success. He attributes trying new things and pushing yourself beyond your limits to moving beyond mediocrity. He believes that if you never fail, you will never learn and that failures can lead to the greatest successes. The concept is that you only have to get it right once, no matter how many times you have failed in the past.

Originally from New York, Jordan Lindsey attended St. Joseph’s College and Mount Angel Seminary. He is a self-taught programmer, systems architecture designer, veteran algo trader, and the founder of JCL Capital. His company gives average investors the opportunity to gain significant monthly returns on forex trading with a systematic approach.

Jordan Lindsay has lived abroad in Mexico, Argentina, and Bosnia-Herzegovina. He appreciates sharing ideas and is an individual who thrives on innovation. For example, the energy of San Francisco immediately struck Jordan the first time he visited. He was highly intrigued with the way people shared their ideas and how they encouraged one another to create. It was only within a few months of returning to New York that he relocated to San Francisco. Jordan Lindsay’s creation of the cryptocurrencies first 100% transparent trading bot is one of his highest achievements.

https://www.youtube.com/watch?v=_N9vIsFzlkc

Jeff Aronin and Paragon Biosciences: Working to Help Patients

One of the great challenges in biotech and pharma today is getting medicines approved. While many ideas come from laboratories around the world, the failure rate is still very high at a time where the need for breakthrough medicines has never been greater. That is the challenge that Paragon Biosciences, and its leader Jeff Aronin, strive to meet every day.

Paragon is a Chicago-based incubator and investor that builds and grows leading biotechnology companies (Alivenewspaper). It uniquely focuses on patient need, the science behind the disease and building great companies to quickly bring novel treatments to patients. Aronin and Paragon have an outstanding track record in what matters most: getting medicines approved, with some 13 new drugs approved, on par with most Big Pharma companies over the past decade.

Paragon always starts with the patient need. When it identifies a debilitating disease with no effective treatment, Aronin and his team move forward quickly to address that need. It is not enough to just realize there may be an opportunity in a certain disease state. What drives the team is the desire to understand what causes a disease, what treatment can help and how can Paragon best bring a treatment to patients.

Paragon Biosciences was created with a straightforward, but important, goal: to build innovative companies that bring important medicines to patients. Paragon’s portfolio companies are managed by healthcare industry leaders and biotech entrepreneurs committed to delivering better health outcomes for patients with diseases that go largely untreated today. With more than 6,000 diseases today that do not have an approved therapy available, the work that Paragon Biosciences, Jeff Aronin, and his team will do has never been more needed or important.

Paragon’s strategy is straightforward: First, learn the disease. Second, understand the science. Third, remove all guesswork. The result is a rational pathway for approval for a medicine that addresses an unmet need.

Jeff Aronin’s strategy and Paragon’s development model are exactly what healthcare needs today: an efficient, focused strategy that puts patients first and addresses true unmet medical needs.